Remedy Raises Series A Round

We are delighted to have closed our Series A funding led by Blackbird with participation from all our existing investors including DCVC, KDT Ventures, Pathbreaker Ventures and Tony Fadell's Future Shape

While this is an important milestone for us as a company we are heads down working towards or development and clinical milestones. More to come!

‍